Abstract: Porphyromonas gingivalis, a Gramnegative anaerobic bacterium, is considered to be one of the major etiologic agents of adult periodontitis. We previously succeeded in molecular cloning of a 200-kDa antigenic protein (200-k AP) from P. gingivalis 381 by immunoscreening using sera from severe periodontitis patients and designated it as pMD101. We also identified amino acid sequences of the short peptide from a lysyl endopeptidase digested recombinant (r), 200-k AP, and found that the short peptide had exactly the same amino acid sequence as the hemagglutinin A (hagA) of P. gingivalis, which is thought to have potential use in a vaccine against periodontitis. In this study, we attempted to confirm whether 200-k AP was a molecule identical to hagA. DNA sequences of pMD157, a subclone encoding the 25-kDa antigenic region of pMD101, were identical to the same part of the hagA gene. The r200-k AP was purified for homogeneity and rabbits were immunized with it. The antibody against r200-k AP previously showed a similar Westernblot pattern as P. gingivalis lysate by monoclonal antibodies against hagA by literature and reacted to r130-kDa hemagglutinin. These findings suggest that 200-k AP is identical to hagA and that r200-k AP may be useful as an immunotherapy agent against periodontitis caused by P. gingivalis infection. (J. Oral Sci. 45, [145][146][147][148][149][150][151][152] 2003) 
Introduction
The onset and progression of adult periodontitis have been shown to be related to the subgingival emergence of a consortium of specific Gram-negative bacteria, as the change from a periodontally healthy to a diseased site is associated with a large increase in the relative abundance of a small number of opportunistic pathogens, including Porphyromonas gingivalis (1, 2) .
We previously constructed a gene library of P. gingivalis 381 chromosomal DNA and successfully cloned a gene encoding the 200-kDa antigenic protein (200-k AP) which was reacted to sera from periodontitis patients, and designated it as pMD101 (3) . Since the recombinant (r) protein from Escherichia coli host cells harboring pMD101 reacted with antiserum against P. gingivalis 381, but not with antisera against other periodontitis associated pathogens, 200-k AP may be a specific antigen of P. gingivalis (3) .
It has also been reported that P. gingivalis has a high adherence activity with erythrocytes and epithelial cells (4) . Hemagglutinins are bacterial surface proteins that often function as adhesins by which bacteria attach to host cells (5) , and multiple hemagglutinin genes have been cloned from P. gingivalis by functional screening (6, 7) . We also cloned a gene encoding the130-kDa hemagglutinin domain (130-kDa HMGD) and determined its functional motifs (8) . To identify 200-k AP, lysyl endopeptidase digested peptides from r200-k AP were separated by reverse-phase high pressure liquid chromatography and the amino acid sequence of a short peptide, VTVPENGK, was shown by a homology search using a protein database (9) to be exactly the same as a region in hagA.
In the present study, to confirm whether 200-k AP was identical to the hagA molecules, we analyzed the sequences of pMD157 DNA, which harbored a subcloned gene from pMD101 encoding the 25-kDa antigenic region (10) , and carried out a DNA homology search using a DNA database. Furthermore, we purified r200-k AP, and then raised an antibody and examined its immunoreactivity.
Materials and Methods
Bacteria and culture P. gingivalis 381 was grown in a brain-heart infusion-0.25% yeast extract supplemented with hemin (5 µg/ml) and vitamin K (0.5 µg/ml). The cultures were incubated at 37°C in an anaerobic chamber (Model 1024, Forma, USA) containing 80% N 2 , 10% H 2 , and 10% CO 2 .
The recombinant Escherichia coli clone, harboring plasmid (pMD101) coding for 200-k AP, was grown on LB (trypton, 1%; yeast extract, 0.5%; NaCl, 0.5%).
Purification of 200-k AP
Escherichia coli K-12 host cells harboring pMD101 were harvested from 10 liters of culture medium by centrifugation at 8500 × g for 30 min at 4°C. The harvested cells were suspended in 100 ml of buffer A (10 mM TrisHCl, pH 7.4) and sonicated at 70 W with a sonifier equipped with a microtip (Ohtake works, Tokyo Japan) in an ice bath, and then centrifuged at 28000 × g for 30 min at 4°C. The supernatant was then dialyzed against buffer A and applied onto a Q Sepharose column (Q Sepharose Hiload, 26 × 100 mm; Pharmacia LKB Biotechnology AB, Uppsala, Sweden) that was equilibrated with buffer A. Proteins were eluted with an increasing gradient of NaCl (0 -500 mM) in buffer A at a flow rate of 2 ml/min. Each collected fraction was dotted onto a nitrocellulose membrane and soaked in TBS buffer (10 mM Tris-HCl; 0.15 M NaCl, pH 7.5) containing 5% low fat milk (TBS-milk) and gently shaken for 30 min. The membrane was then incubated with antiserum against P. gingivalis 381 (500-fold dilution in TBS-milk) at room temperature for 1 hr, followed by peroxidase-conjugated goat anti-rabbit IgG (1000-fold dilution in TBS-milk; ICN Biochemicals, Ohio, USA) at room temperature for 1 hr. Peroxidase activities were detected by incubating the filter with TBS buffer, which contained 0.08% 3,3'-diaminobenzidine tetrahydrochloride and 0.05% H 2 O 2 . Immunoreactive fractions were detected using a goat antibody against rabbit immunoglobulins and eluted with an increasing gradient of NaCl (0 -500 mM) in buffer A at a flow rate of 2 ml/min. Immunoreactive fractions were pooled and solid ammonium sulfate was added to obtain a 30% saturation. The pellet was dissolved with a loading buffer (60 mM Tris-HCl, 1% SDS, 7% glycerol, pH 6.8) and passed through a 0.22 µm membrane filter. The r130-kDa HMGD protein was then purified by electro-osmotic preparative disc gel electrophoresis (11) .
Western blot analysis
The mini slab SDS-polyacrylamide gel electrophoresis (PAGE) gel (7 × 8 cm; 1.0 mm thick) was composed of a 7% separation gel and 4.5% tracking gels. Proteins separated on the SDS-PAGE gel were transferred to a nitrocellulose membrane and probed with antibodies. Western blot analysis was carried out using a previously reported procedure (3). For antibodies, rabbit antibody against r200-k AP, MAb-Pg-vc (8) and MAb Pg-omp-A2 was used. For antigens, P. gingivalis 381 cell extracts and r130-kDa HMGD (8) were used as positive controls and the r40-kDa outer membrane protein of P. gingivalis (12) was used as a negative control.
Nucleotide sequencing and homology search Dideoxy-chain termination sequencing (13) was performed with fluorescent dye-labeled T7 universal primers (Aloka, Japan) using SequiTherm™ Long-Read™ cycle sequencing kits for LI-COR ® sequencing (Epicentre Technologies, USA).
A homology search of the DNA sequence and the amino acid sequences of the cloned DNA was carried out by the basic local alignment search tool (BLAST) using a standard nucleotide-nucleotide BLAST (blastn) and a standard protein-protein BLAST (blastp) homology search in National Center for Biotechnology Information (NCBI) databases, respectively.
Results
Fig . 1A shows the entire DNA sequences of inserted DNA in pMD157, while previous localization of the short peptide 8 amino acid sequences, VTVPENGK (9), as the deduced amino acid sequences. A blastin homology search demonstrated significant alignments to several identical genes related to hagA (Fig. 1B) . Fig. 1C shows homologous DNA sequences of the DNA inserts in pMD157 to the P. gingivalis hemagglutinin A (hagA) gene, which showed the greatest alignments. The genetic and protein maps of hagA and pMD157 inserts, as well as their localizations, are shown in Fig. 2 .
Next, we purified r200-k AP using serial column chromatography. As shown in Fig. 3 , the final purified sample was homogeneous in the SDS-PAGE results. Since we also constructed a MAb against r130-kDa HMGD, which has functional motifs for hemagglutinin (8) , and the immunoreactivity of 200-k AP toward antibodies against purified r200-k AP, MAb-Pg-vc and MAb Pg-omp-A2 were examined. As shown in Fig. 4 , purified r200-k AP reacted with antibodies against r200-k AP and MAb-Pgvc, however not with those against MAb Pg-omp-A2.
Finally, a purified r200-k AP sample was immunized as an immunogen to rabbits to raise a specific antibody, after which immunoreactivity of the antibody against r200-k AP, cell extracts of P. gingivalis 381, r130-kDa HMGD, and r40-kDa OMP, were examined by Western blotting. As shown in Fig. 5 , Western blot analysis showed that the antibody against r200-k AP recognized r200-k AP, 2 major 43 and 49-kDa bands as well as other smaller bands in cell extracts of P. gingivalis 381 cells and r130-kDa HMGD, however, it did not react with r40-kDa OMP as a negative control.
Discussion
HagA has been reported to be 7887 bp in length, and encode a protein of 2628 amino acids, with a molecular mass of 283.3 kDa (14) . Within its open reading frame, 4 direct repeats have been identified, as well as the repeat unit that is assumed to contain the hemagglutinin domain. Recently, it has been shown that hagA, a major virulenceassociated surface protein, is a potentially useful immunogen, as it elicits an immune response that may be protective against colonization by P. gingivalis (15) . Prior reports of short peptide amino acid sequences (9) in r200-k AP led us to speculate that the gene encoding 200-k AP may be identical to the hagA gene of P. gingivalis. We found that DNA sequences of pMD157, a subcloned gene encoding the 25-kDa antigenic region of pMD101, were identical to the first repeat in hagA (964 -1818) (Figs. Fig. 3 Purification of r200-k AP. Samples and size markers were run on SDS-PAGE and stained with Coomassie Blue G-250. 1 size marker; 2 cell extracts from E. coli HB101; 3 cell extracts from E. coli HB101 pMD157; 4 final purified sample. 1,2). Moreover, r200-k AP was purified homogeneously and the subsequently raised antibody showed similar Western blot profiles to P. gingivalis lysates with monoclonal antibodies against hagA as reported by Kozalov et al. (15) (Fig. 4) . These findings demonstrated that the 200-k AP gene is a part of hagA. We previously cloned the gene encoding 130-kDa HMGD and identified the functional motifs of hemagglutination. The gene families specifying this motif are found in 14 registered genes in the chromosomal DNA of P. gingivalis strains, and encode many hemagglutinin or hemagglutinin-related molecules, including prtK (from P. gingivalis strain, W50), prtP (W12), kgp (W83, 381), rgp-1 (H66), prtR (W50), prpR1 (W50), prtH (W83), prtRII (381), rgp2 (H66), rgpB (381), HagD (381), and hagA (381) (8) . The results of the Western blot analysis presented in Fig. 4 demonstrate that the antibody of r200-k AP reacted with 130-kDa HMGD, which also shows the existence of similar antigenic domains between r200-k AP and 130-kDa HMGD.
It is well known that the adherence of bacteria to host tissue cells is a prerequisite for colonization and one of the causative factors of bacterial pathogenesis. Further, hemagglutinin molecules are thought to be important virulent factors such as with colonization on gingival tissues and agglutination of erythrocytes, which are critical in the pathogenic process of periodontal disease. In addition, proteinase-hemagglutinin complexes may have important roles in the uptake of hemin, which is a requirement for the growth of P. gingivalis (16) , via hemagglutination and the subsequent hemolysis of erythrocytes (17) . Taken together, these findings show that 200-k AP may be a useful tool for the development of a component vaccine against periodontitis caused by P. gingivalis infection.
Passive immunization approaches against oral infectious diseases have been developed (18) . Patients with periodontitis who harbored P. gingivalis in their subgingival plaque were clinically treated to suppress any detectable P. gingivalis, and then the antibody against those bacterium cells was applied to their periodontal pockets. Such treatment significantly reduced the recolonization of P. gingivalis for up to 9 months (19) . When considering passive immunization against periodontal diseases, the pathological focus should be on gingival tissues, and application of a specific antibody that neutralizes bacterial agglutination and hemolytic activity may provide practical and satisfactory treatment. Thus, the antibody may be useful in the development of passive immunization against for periodontal diseases caused by P. gingivalis infection.
